Akero Therapeutics, Inc. Shareholders' Equity
Akero Therapeutics, Inc. had Shareholders' Equity of $957.64 million as of 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2025-11-07
- 2025-09-30: Stockholders' Equity Attributable to Parent $957.64M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $1.03B.
- 2025-03-31: Stockholders' Equity Attributable to Parent $1.08B.
- 2024-12-31: Stockholders' Equity Attributable to Parent $750.11M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-09-30 | $957.64M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $1.03B 10-Q · filed 2025-11-07 |
| 2025-03-31 | $1.08B 10-Q · filed 2025-11-07 |
| 2024-12-31 | $750.11M 10-Q · filed 2025-11-07 |
| 2024-09-30 | $738.33M 10-Q · filed 2025-11-07 |
| 2024-06-30 | $798.07M 10-Q · filed 2025-11-07 |
| 2024-03-31 | $846.25M 10-Q · filed 2025-11-07 |
| 2023-12-31 | $535.31M 10-Q · filed 2025-11-07 |
| 2023-09-30 | $583.13M 10-Q · filed 2024-11-08 |
| 2023-06-30 | $616.44M 10-Q · filed 2024-11-08 |
| 2023-03-31 | $306.35M 10-Q · filed 2024-11-08 |
| 2022-12-31 | $326.56M 10-K · filed 2025-02-28 |
| 2022-09-30 | $343.51M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $148.37M 10-Q · filed 2023-11-13 |
| 2022-03-31 | $146.53M 10-Q · filed 2023-11-13 |
| 2021-12-31 | $169.11M 10-K · filed 2025-02-28 |
| 2021-09-30 | $198.63M 10-Q · filed 2022-11-04 |
| 2021-06-30 | $220.13M 10-Q · filed 2022-11-04 |
| 2021-03-31 | $246.02M 10-Q · filed 2022-11-04 |
| 2020-12-31 | $258.71M 10-K · filed 2024-02-29 |
| 2020-09-30 | $286.46M 10-Q · filed 2021-11-12 |
| 2020-06-30 | $103.66M 10-Q · filed 2021-11-12 |
| 2020-03-31 | $118.32M 10-Q · filed 2021-11-12 |
| 2019-12-31 | $128.73M 10-K · filed 2022-02-25 |
| 2019-09-30 | $143.38M 10-Q · filed 2020-11-12 |
| 2019-06-30 | $158.39M 10-Q · filed 2020-11-12 |
| 2019-03-31 | -$55.07M 10-Q · filed 2020-11-12 |
| 2018-12-31 | -$49.92M 10-K · filed 2022-02-25 |
| 2018-09-30 | -$25.09M 10-Q · filed 2019-11-12 |
| 2018-06-30 | -$13.73M 10-Q · filed 2019-11-12 |
| 2018-03-31 | -$4.99M 10-Q · filed 2019-11-12 |
| 2017-12-31 | -$4.56M 10-K · filed 2020-03-16 |